๐Ÿ”Ž Trials Near Me

Home โ€บ Proteinuria

Proteinuria clinical trials recruiting in the U.S.

17 studies for Proteinuria are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases

RecruitingPhase 2
Ages 18 to 115 ยท All sexes ยท Updated Sep 29, 2026 ยท NCT06664814

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

RecruitingPhase 2
Ages 18 to 60 ยท All sexes ยท Updated Sep 25, 2026 ยท NCT07541287

Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

RecruitingPhase 2
Ages 18 to 90 ยท All sexes ยท Updated Sep 22, 2026 ยท NCT00977977

Urinary Vitamin C Loss in Diabetic Subjects

RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 65 ยท All sexes ยท Updated Sep 22, 2026 ยท NCT00071526

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

RecruitingPhase 3
Ages 2 to 18 ยท All sexes ยท Updated Sep 9, 2026 ยท NCT06994845

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Aug 13, 2026 ยท NCT07268638

A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

RecruitingPhase 2
Ages 18 to 100 ยท All sexes ยท Updated Aug 10, 2026 ยท NCT07146906

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

RecruitingPhase 2
Ages 18 to 100 ยท All sexes ยท Updated Jul 30, 2026 ยท NCT05268289

Study of Ravulizumab in Pediatric Participants With Primary IgAN

RecruitingPhase 3
Ages 2 to 18 ยท All sexes ยท Updated Jul 30, 2026 ยท NCT07024563

Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Jul 30, 2026 ยท NCT07224776

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

RecruitingPhase 3
Ages 12 to 60 ยท All sexes ยท Updated Jul 13, 2026 ยท NCT05755386

Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

RecruitingPhase 3
Ages 12 to 60 ยท All sexes ยท Updated Jul 13, 2026 ยท NCT04817618

Study of BHV-1400 in IgA Nephropathy

RecruitingPhase 1
Ages 18 to 65 ยท All sexes ยท Updated Jun 23, 2026 ยท NCT07054684

Empagliflozin Treatment in Kidney Transplant Recipients

RecruitingPhase 4
Ages 19 and older ยท All sexes ยท Updated Apr 21, 2026 ยท NCT06013865

Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)

RecruitingObservational studyHealthy volunteers welcome
Ages 7 to 18 ยท All sexes ยท Updated Dec 11, 2025 ยท NCT04752293

Proteinuria in Pre and Post Transplant

RecruitingObservational study
Up to age 25 ยท All sexes ยท Updated Nov 21, 2025 ยท NCT01094327

Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center

RecruitingObservational studyHealthy volunteers welcome
All ages ยท All sexes ยท Updated Oct 4, 2024 ยท NCT01016613

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.